Sign in

CIK 0001645469

  • Non-accelerated filer
  • Smaller reporting company

Monopar Therapeutics

Sign in to watch
Ticker
MNPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320463781
Phone
+1 847-388-0349
Business address
1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,335,315
in 9 filings, $5.3M under 10b5-1 plans

Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-02-02 KLAUSNER ARTHUR J Director Grant or award · Restricted Stock Units +11,436 11,436
2022-02-02 Cittadine Andrew Chief Operating Officer Grant or award · Stock Options +85,000 85,000
2022-02-02 Cittadine Andrew Chief Operating Officer Grant or award · Restricted Stock Units +65,000 65,000
2022-01-01 Mazar Andrew Paul Chief Scientific Officer Exercise or conversion +1,937 21,660.8
2022-01-01 Mazar Andrew Paul Chief Scientific Officer Shares withheld for taxes −671 $3.21 $2K 20,989.8
2022-01-01 Mazar Andrew Paul Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,937 3,874
2022-01-01 Tsuchimoto Kim R Chief Financial Officer Exercise or conversion +1,231 5,420
2022-01-01 Tsuchimoto Kim R Chief Financial Officer Shares withheld for taxes −505 $3.21 $2K 4,915
2022-01-01 Tsuchimoto Kim R Chief Financial Officer Exercise or conversion · Restricted Stock Units −1,231 2,461
2022-01-01 Robinson Chandler Chief Executive Officer Exercise or conversion +6,724 36,059.8
2022-01-01 Robinson Chandler Chief Executive Officer Shares withheld for taxes −2,327 $3.21 $7K 33,732.8
2022-01-01 Robinson Chandler Chief Executive Officer Exercise or conversion · Restricted Stock Units −6,724 13,447
2022-01-01 RIOUX PATRICE Acting Chief Medical Officer Grant or award · Stock Options +10,000 10,000
2021-12-31 Mazar Andrew Paul Chief Scientific Officer Exercise or conversion +1,606 20,279.8
2021-12-31 Mazar Andrew Paul Chief Scientific Officer Shares withheld for taxes −556 $3.21 $2K 19,723.8
2021-12-31 Mazar Andrew Paul Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,606 19,273
2021-12-31 Tsuchimoto Kim R Chief Financial Officer Exercise or conversion +1,221 4,690
2021-12-31 Tsuchimoto Kim R Chief Financial Officer Shares withheld for taxes −501 $3.21 $2K 4,189
2021-12-31 Tsuchimoto Kim R Chief Financial Officer Exercise or conversion · Restricted Stock Units −1,221 14,652
2021-12-31 Robinson Chandler Chief Executive Officer Exercise or conversion +3,941 30,699.8

Page 20 of 28 · 549 trades